Vivo Capital, LLC Iveric Bio, Inc. Transaction History

Vivo Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $44.7 Million - $88.4 Million	-4,755,221 Reduced 90.77%	483,413 $8.67 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $10.9 Million - $22.6 Million	-1,193,306 Reduced 18.55%	5,238,634 $50.4 Million
Q1 2022 May 13, 2022	BUY	$12.15 - $16.83 $1.71 Million - $2.37 Million	141,113 Added 2.24%	6,431,940 $108 Million
Q4 2021 Feb 11, 2022	BUY	$13.83 - $18.78 $4.49 Million - $6.09 Million	324,300 Added 5.44%	6,290,827 $105 Million
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $18.3 Million - $39.4 Million	5,966,527 New	5,966,527 $30.4 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.